Zymeworks
ZYME
91 hedge funds and large institutions have $293M invested in Zymeworks in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 27 reducing their positions, and 34 closing their positions.
204% more call options, than puts
Call options by funds: $1.58M | Put options by funds: $519K
32% more capital invested
Capital invested by funds: $223M → $293M (+$70.9M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 27
5.11% less ownership
Funds ownership: 82.55% → 77.44% (-5.1%)
19% less funds holding
Funds holding: 113 → 91 (-22)
65% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 34
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$19.9M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$11.6M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$5.21M |
| 4 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
+$1.79M |
| 5 |
PA
Perceptive Advisors
New York
|
+$1.61M |
Top Sellers
| 1 |
CAC
Cowen and Company
New York
|
-$7.95M |
| 2 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
-$6.82M |
| 3 |
MS
Maven Securities
St Helier,
Jersey
|
-$6.5M |
| 4 |
Goldman Sachs
New York
|
-$6.25M |
| 5 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$3.15M |
ZYME Hedge Fund Activity: Q3 2022 in Review
91 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2022, worth a combined $293M — up 32% from $223M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of ZYME and 12 opened new positions — a net loss of 22 holders — while 27 trimmed existing stakes and 27 added.
The largest buyer was Morgan Stanley, adding an estimated $19.9M. The largest seller was Cowen and Company, exiting entirely with an estimated $7.95M sold.
- 91 institutional investors held Zymeworks (ZYME) as of Q3 2022, down from 113 in Q2 2022.
- Funds reported $293M of Zymeworks stock for Q3 2022, up 32% quarter-over-quarter.
- 12 funds opened new Zymeworks positions in Q3 2022 and 34 closed out, a net change of -22 holders.
- The largest Zymeworks buyer in Q3 2022 was Morgan Stanley, an estimated $19.9M added.
- The largest Zymeworks seller in Q3 2022 was Cowen and Company, an estimated $7.95M sold.
Based on aggregated 13F filings for Q3 2022.